# Use cases


## Quetiapine

## Adverse events





FDA Adverse Event Reporting System ([FAERS](https://open.fda.gov/data/faers/)). [Here](https://open.fda.gov/apis/drug/event/) is quick explanation:
<!--html_preserve--><div id="htmlwidget-00ebf24659b9e264dfb9" style="width:100%;height:400px;" class="plotly html-widget"></div>
<script type="application/json" data-for="htmlwidget-00ebf24659b9e264dfb9">{"x":{"visdat":{"3e50642d5411":["function () ","plotlyVisDat"]},"cur_data":"3e50642d5411","attrs":{"3e50642d5411":{"x":{},"y":{},"alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"bar"}},"layout":{"margin":{"b":40,"l":60,"t":25,"r":10},"title":"Adverse drug events reported to FDA for quetiapine","xaxis":{"domain":[0,1],"automargin":true,"title":"","categoryorder":"count","categoryarray":[16416,16393,8068,7140,6399,5202,4795,3798,3229,2536,2131,1885,1780,1744,1671,1658,1373,1328,1326,1304,1293,1265,1240,1119,1095,1078,992,972,954,926,896,859,852,846,834,800,799,798,794,761,705,695,666,635,634,604,585,576,573,572,569,558,554,520,518],"type":"category"},"yaxis":{"domain":[0,1],"automargin":true,"title":"Events reported"},"hovermode":"closest","showlegend":false},"source":"A","config":{"showSendToCloud":false},"data":[{"x":["depression","bipolar","anxiety","schizophrenia","sleep","insomnia","pain","hypertension","psychotic","parkinson","diabetes","dementia","schizoaffective","gastrooesophageal","affective","hallucination","arthritis","agitation","sclerosis","hyperactivity","infection","attention","stress","traumatic","hypothyroidism","pulmonary","narcolepsy","rheumatoid","mood","constipation","asthma","delusion","migraine","psychosis","mania","muscle","panic","hepatitis","cancer","cardiac","nausea","personality","fibromyalgia","epilepsy","paranoid","obsessive","thyroid","compulsive","convulsion","crohn","thrombosis","attack","psoriasis","myeloma","headache"],"y":[16416,16393,8068,7140,6399,5202,4795,3798,3229,2536,2131,1885,1780,1744,1671,1658,1373,1328,1326,1304,1293,1265,1240,1119,1095,1078,992,972,954,926,896,859,852,846,834,800,799,798,794,761,705,695,666,635,634,604,585,576,573,572,569,558,554,520,518],"type":"bar","marker":{"color":"rgba(31,119,180,1)","line":{"color":"rgba(31,119,180,1)"}},"error_y":{"color":"rgba(31,119,180,1)"},"error_x":{"color":"rgba(31,119,180,1)"},"xaxis":"x","yaxis":"y","frame":null}],"highlight":{"on":"plotly_click","persistent":false,"dynamic":false,"selectize":false,"opacityDim":0.2,"selected":{"opacity":1},"debounce":0},"shinyEvents":["plotly_hover","plotly_click","plotly_selected","plotly_relayout","plotly_brushed","plotly_brushing","plotly_clickannotation","plotly_doubleclick","plotly_deselect","plotly_afterplot","plotly_sunburstclick"],"base_url":"https://plot.ly"},"evals":[],"jsHooks":[]}</script><!--/html_preserve--> To better understand what this data means, we need to really dig into the openFDA API.

[SUSAR](https://bi.ema.europa.eu/analyticsSOAP/saw.dll?PortalPages&PortalPath=%2Fshared%2FPHV%20DAP%2F_portal%2FDAP&Action=Navigate&P0=1&P1=eq&P2=%22Line%20Listing%20Objects%22.%22Substance%20High%20Level%20Code%22&P3=1+21689)

[EudraVigil](http://www.adrreports.eu/de/search_subst.html#)

## Enasidenib

## Deep Brain Stimulation 

## Somatic genome-editing
